Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights Life Science Investing
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer Life Science Investing
Incyte's Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema Life Science Investing
Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015 Life Science Investing
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights Life Science Investing
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates Life Science Investing
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis Life Science Investing
Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, "NEO-CYT", in High-Risk, Surgically Resectable Stage III Melanoma Life Science Investing
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates Life Science Investing
